|
Dulaglutide 0.75Mg/0.5Ml Inj Pen Clinical Trials
1 actively recruiting trial across 1 location
Aurora, Colorado1 trial
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
Children's Hospital of Colorado
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.